Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Control Group (general participants):
- People aged 50 years or older.
- People who are able to walk 4 meters on their own without using a walking aid such as a cane or walker.
- People who expect to be available and able to participate for 12 months.
- People who are able to give informed consent and follow the study's required steps and procedures.
- People who are willing to wear a small sensor device to track their movement and mobility.
- People who are able to read and write in their first language in the country where the trial is taking place.
Parkinson's Disease (PD) Group:
- People who are already taking part in a related study called the Mobilise-D Clinical Validation Study (CVS) PD Cohort.
- People aged 18 or older.
- People who have been clinically diagnosed with Parkinson's disease according to the Movement Disorder Society's current diagnostic criteria.
- People whose Parkinson's disease is rated at stage I, II, or III on the Hoehn & Yahr scale, which generally reflects mild to moderate disease severity (confirm with trial site).
Who may not be able to join:
Control Group:
- People who have had any of the following within the 3 months before signing up: a heart attack, a hospital stay for unstable chest pain (angina), a stroke, heart bypass surgery, a procedure to open blocked heart arteries, a heart device implant for rhythm problems, active treatment for cancer or another malignant disease, severe uncontrolled heart failure, an episode of acute psychosis or a major psychiatric condition, ongoing substance misuse, or a neurological or bone and joint problem that significantly affects the way they walk.
- People who have already been diagnosed with Parkinson's disease, chronic obstructive pulmonary disease (COPD), a hip fracture near the hip joint, or multiple sclerosis (MS).
- People with a history of dementia, significant memory or thinking problems, or a movement disorder such as essential tremor.
PD Group:
- People whose medical history points to a condition called Dementia with Lewy Bodies, or an atypical form of parkinsonism such as multiple system atrophy or progressive supranuclear palsy, diagnosed using accepted medical criteria.
- People who have had repeated strokes or a step-by-step worsening of symptoms that has led to a diagnosis of 'vascular parkinsonism' (parkinsonism caused by problems with blood flow to the brain).
- People whose Parkinson's-like symptoms are caused by medication rather than a disease process.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Alison Yarnall, PhD, Newcastle University
Phone: +44 (0) 191 2081406
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in LLFDI in controls; Change in LLFDI in PD; Change in fall frequency in PD
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.